Drug Type Recombinant protein |
Synonyms ZG 002, ZG002 |
Target |
Mechanism TYK2 inhibitors(Tyrosine-protein kinase 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Plaque psoriasis | Phase 1 | CN | 22 Oct 2024 | |
Blood Loss, Surgical | Preclinical | CN | - | |
Hemophilia A | Preclinical | CN | - |